Odyssey Therapeutics, Inc. (ODTX)
Nasdaq: ODTX · Biological Products, (No Diagnostic Substances) · filing with the SEC since 2021
Who runs Odyssey Therapeutics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Glick Gary D
President and Chief Executive Officer. First filing May 2026, latest May 11, 2026, 0 filings in all.
Officers reporting now
6
of 17 people with a filing in the last fifteen months
Directors reporting now
11
17 people on the record since 2026
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Glick Gary D | President and Chief Executive Officer | May 2026 | May 11, 2026 | none |
| Opipari Anthony W. | Interim Chief Medical Officer and Executive Vice President, Translational Medicine | May 2026 | May 11, 2026 | none |
| Todd Collin M | Senior Vice President, Strategy and Business Development | May 2026 | May 11, 2026 | none |
| Haas Jason | Chief Financial Officer | May 2026 | May 11, 2026 | none |
| Dales Natalie | Chief of Research Operations and Portfolio Strategy | May 2026 | May 11, 2026 | none |
| Siegel Jolie | Executive Vice President, General Counsel and Secretary Exhibit 24 - Power of Attorney | May 2026 | May 7, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Dimension Capital II, L.P. | director | May 2026 | May 12, 2026 | none |
| Chu Shelley | director | May 2026 | May 11, 2026 | none |
| Leiden Jeffrey M | director | May 2026 | May 11, 2026 | none |
| Li Nan (Ln) | director | May 2026 | May 11, 2026 | none |
| Odegard Valerie | director | May 2026 | May 11, 2026 | none |
| Smith Ian F | director | May 2026 | May 11, 2026 | none |
| Tatsis Ourania | director | May 2026 | May 11, 2026 | none |
| Walbert Timothy P | director | May 2026 | May 11, 2026 | none |
| Hill Paulina | director | May 2026 | May 7, 2026 | none |
| Ng Carolyn | director | May 2026 | May 7, 2026 | none |
| Pavletic Aranicki Ksenija | director | May 2026 | May 7, 2026 | none |
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Coulter James G | 10% owner | May 2026 | May 13, 2026 | none |
| Tpg Gp A, LLC | 10% owner | May 2026 | May 13, 2026 | none |
| Winkelried Jon | 10% owner | May 2026 | May 13, 2026 | none |
| George Simeon | 10% owner | May 2026 | May 11, 2026 | 3 · $0.00 |
| Sr One Capital Management, LLC | 10% owner | May 2026 | May 11, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.